Author(s):
Nurul Hasanah, Eva Rachmi, Hadi Irawiraman
Email(s):
n.hasanah@fk.unmul.ac.id
DOI:
10.52711/0974-360X.2025.00694 
Address:
Nurul Hasanah1, Eva Rachmi2, Hadi Irawiraman3
1Laboratory of Histology, Faculty of Medicine, Mulawarman University, Samarinda, Indonesia.
2Laboratory of Anatomy, Faculty of Medicine, Mulawarman University, Samarinda, Indonesia.
3Laboratory of Anatomical Pathology, Faculty of Medicine, Mulawarman University, Samarinda, Indonesia.
*Corresponding Author
Published In:
Volume - 18,
Issue - 10,
Year - 2025
ABSTRACT:
Breast cancer is the most common cancer in women and one of the leading causes of morbidity and mortality in women worldwide. In Indonesia there are approximately 65,000 new cases, in 2020. Expression of HER-2 and Ki-67 were used as markers to determine the prognosis and predict the response of a certain therapeutic modality in breast cancer. This study aims to determine the relationship between the expression of HER-2 and Ki-67 with the histopathological grade in breast cancer. This research was a cross-sectional analytical study using secondary data obtained from 50 samples of breast cancer at Abdoel Wahab Sjahranie Hospital Samarinda during 2019 using purposive sampling technique. The Chi Square test was used to assess all of the data. The relationship between the expression of HER-2 and Ki-67 with the histopathological grade resulted in p-values of 0.334 and 0.115, respectively. There was no significant relationship between the expression of HER-2 and Ki-67 with the histopathological grade of breast cancer in Abdoel Wahab Sjahranie Hospital, Samarinda, East Borneo Indonesia.
Cite this article:
Nurul Hasanah, Eva Rachmi, Hadi Irawiraman. Expression of Human Epidermal Receptor 2 (HER-2) and Ki-67 is not associated with the histopathological grade in breast cancer at Abdoel Wahab Sjahranie Hospital, Samarinda, East Borneo, Indonesia. Research Journal of Pharmacy and Technology. 2025;18(10):4815-0. doi: 10.52711/0974-360X.2025.00694
Cite(Electronic):
Nurul Hasanah, Eva Rachmi, Hadi Irawiraman. Expression of Human Epidermal Receptor 2 (HER-2) and Ki-67 is not associated with the histopathological grade in breast cancer at Abdoel Wahab Sjahranie Hospital, Samarinda, East Borneo, Indonesia. Research Journal of Pharmacy and Technology. 2025;18(10):4815-0. doi: 10.52711/0974-360X.2025.00694 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-10-33
REFERENCES:
1. Becker S. A historic and scientific review of breast cancer: The next global health care challenge. International Journal of Gynecology and Obstetrics. 2015; S36-S39. doi: 10.1016/j.ijgo.2015.03.015
2. Patidar A. Shivhare SC. Ateneriya U. Choudhary SA. Comprehensive Review on Breast Cancer. Asian J. Nur. Edu. and Research. 2012; 28-32. doi:10.5958/j.0976-5506.4.3.127
3. Yi M. Ryu MR. The Effects of Breast Health Education in Women with Breast Cancer. Research J. Pharm. and Tech 2017; 2295-2302. doi: 10.5958/0974-360X.2017.00407.3
4. International Agency for Research on Cancer. GLOBOCAN 2020: Breast Cancer. The Global Cancer Observatory. 2020. https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf.
5. Kementerian Kesehatan Republik Indonesia, Riset Kesehatan Dasar: Jenis Kanker Terbanyak pada Pria dan Wanita di Indonesia. 2018
6. Dhia S. Hubungan Faktor-Faktor Treatment Delay Dengan Kasus Kanker Payudara Stadium Lanjut Di RSUD Abdul Wahab Sjahranie Samarinda Tahun 2019. Motiva Jurnal Psikologi. 2019; 74-81. doi:10.31293/mv.v2i2.4807
7. Rosai J. Rosai and Ackerman's Surgical Pathology E-Book. Elsevier Health Sciences, 2011. ISBN 032308804X, 9780323088046
8. Asif H. Sultana S. Ahmed S. Akhtar N. Tariq M. HER-2 Positive Breast Cancer - a Mini-Review. Asian Pacific Journal of Cancer Prevention. 2016; 1609-15. doi:10.7314/APJCP.2016.17.4.1609
9. Dange VN. Shid SJ. Magdum CS. Mohite SK. A Review on Breast cancer: An Overview. Asian J. Pharm. Res. 2017; 49-51. doi:10.5958/2231-5691.2017.00008.9
10. Mohammed AA. Quantitative assessment of Ki 67 expression in correlation with various breast cancer characteristics and survival rate;cross sectional study. Annals of Medicine and Surgery. 2019; 129-134. doi:10.1016/j.amsu.2019.11.005
11. Ragab HM. Samy N. Afify M. Maksoud N. Shaaban HM. Assessment of Ki-67 as a potential biomarker in patients with breast cancer. Journal of Genetic Engineering and Biotechnology 2018; 479-484. doi:10.1016/j.jgeb.2018.03.002
12. Karale PA. Karale MA. Utikar MC. Advanced Molecular Targeted Therapy in Breast Cancer. Res. J. Pharmacology and Pharmacodynamics. 2018; 29-37.
13. Joensuu K. Leidenius M. Kero M. Andersson LC. Horwitz KB. Heikkilä P. ER, PR, HER2, Ki-67 and CK5 in early and late relapsing breast cancer—Reduced CK5 expression in metastases. Breast Cancer: Basic and Clinical Research. 2013; 25-34. doi:10.4137/BCBCR.S10701
14. He L. Long L. Antani S. Thoma G. Computerassisted diagnosis in histopathology. Chapter15.USA:National Institutes of Health. 2010. doi: 10.1117/2.1201011.003358
15. Ermiah, E. Buhmeida,A. Abdalla, F. Khaled, B. R. Salem, N. Pyrhönen, S. Collan,Y. Prognostic value of proliferation markers:immunohistochemical ki-67 expression and cytometrics-phase fraction of women with breast cancer in Libya. Journal of Cancer. 2012; 421-431. doi: 10.7150/jca.4944
16. Asaad, S.A. Hormone Receptor Status and its Relation to C-Reactive Protein and other Prognostic factors in Breast Cancer in Jableh- Syria. Research J. Pharm. and Tech. 2017: 3003-3010. doi: 10.5958/0974-360X.2017.00532.7.
17. Rakha E.A. Reis-Filho J.S. Baehner F. Dabbs D.J. Decker T. Eusebi V. Fox S.B. Ichihara S. Jacquemier J. Lakhani S.R. Palacios J. Richardson A.L. Schnitt S.J. Schmitt F.C. Tan P. Tse G.M. Badve S. Ellis I.O. Breast cancer prognostic classification in themolecular era: the role of histopatological grade. Breast Cancer Research. 2010; 207. doi: 10.1186/bcr2607
18. Lakhani SR, Rakha E, Simpson PT. Invasive lobular carcinoma: WHO Classification of Tumors of the Breast, 4th edition, France: IARC Press, Lyon. 2012. ISBN-13.
19. Mahlevi, D. Korelasi Ekspresi Pemeriksaan Imunohistokimia Ki-67 Dengan Stadium Karsinoma Payudara Di Instalasi Patologi Anatomi Rumah Sakit Umum Daerah Dr. Saiful Anwar Malang Periode Januari 2013–Desember 2015. 2016. URL: http://repository.ub.ac.id/id/eprint/125873.
20. Nanto, S. S. Muhartono, M. Wulan, A. J. Peran Estrogen Receptor (ER), Progesteron Receptor (PR), dan Human Epidermal Growth Factor Receptor 2 (HER-2) untuk Memprediksi Stadium Klinis Kanker Payudara. Jurnal Agromedicine. 2017; 4(2): 256-259. URL:http://repository.lppm.unila.ac.id/8526/1/agro%20des%202017.pdf
21. Hutagalung, S. Mulyadi, I.. Artha, I. Ekspresi Ki-67dan HER-2/neu Berhubungan dengan Derajat Histopatologik Karsinoma Payudara Invasif No Special Type (NST). Majalah Patologi. 2014; 23(2).
22. Gulzar, R. Shahid,R. Saleem,O. Molecular sub types of breast cancer by immunohistochemical profiling. Int. J. Pathol, 2018; 129-134.
23. Kumar, V. Abbas, A. K. Aster, J. C. Cornain, S. Nasar, I. M. Buku ajar patologi Robbins Ed 9. Elsevier (Singapore). 2015.
24. Sampoornam. W. Stress and Quality of Life among Breast Cancer Patients. Asian J. Nur. Edu. and Research. 2014; 325-327. doi: 10.5958/2349-2996
25. Geetha, M. Menaka, K. Padmavathi, P. Awareness of Breast self-examination and risk factors of Breast Cancer among Women. Asian J. Nur. Edu. and Research. 2017; 413-416. doi: 10.5958/2349-2996.2017.00082.9
26. Padmaja A. Mohanasundari S.K. Munuswamy, Murali, K. Sesha Kumar. Evaluate The effectiveness of Awareness programme with health Education on breast cancer and skill Training on breast self-Examination among rural women in chittoorDist Andhra Pradesh-A Collaborative Research. Asian J. Nursing Education and Research. 2020; 97-102. doiI: 10.5958/2349-2996.2020.00022.1
27. Lakshmi K. M. Jaseela K. T. Anjana P. AyishaSithara M. T. Dhrishya. Assess the awareness regarding Early Identification, Prevention and Management of Breast Cancer among Early Adult Women. Asian J. Nursing Education and Research. 2019; 04-08. doi: 10.5958/2349-2996.2019.00002.8
28. Rukmi, D. K. Handayani, D. Faktor risiko kanker payudara pada wanita di RSUD Panembahan Senopati Bantul. Media Ilmu Kesehatan. 2014; 140-147. doi: 10.30989/mik.v3i3.130
29. Rakha E.A. Reis-Filho J.S. Baehner F. Dabbs D.J. Decker T. Eusebi V. Fox S.B. Ichihara S. Jacquemier J. Lakhani S.R. Palacios J. Richardson A.L. Schnitt S.J. Schmitt F.C. Tan P. TseG.M. BadveS. EllisI.O. Breast cancer prognostic classificationin the molecular era: the role of histopatological grade. Breast Cancer Research. 2010; 207. doi: 10.1186/bcr2607
30. Suciu, C. Muresan, A. Cornea, R. Suciu, O. Dema, A. Raica, M. 2014. Semiautomate devaluation of Ki-67 index in invasive ductal carcinoma of the breast. Oncol Lett. 2014; 107–114. doi: 10.3892/ol.2013.1654.